Outlook Therapeutics annual free cash flow
2015
2016
2017
2018
2019
Outlook Therapeutics Free Cash Flow (FCF) History (OTLK)
Outlook Therapeutics reported −$32.7M in free cash flow for fiscal 2019, an increase of $3.1M from the previous fiscal year, with a free cash flow margin of −401.75%.
View full Outlook Therapeutics company overviewOutlook Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-09-30 | −$32.7M | $3.1M | — | −401.75% |
| 2018 | 2018-09-30 | −$35.8M | −$20.0M | — | −1160.16% |
| 2017 | 2017-09-30 | −$15.8M | $30.8M | — | −414.46% |
| 2016 | 2016-09-30 | −$46.6M | −$10.3M | — | −1563.34% |
| 2015 | 2015-09-30 | −$36.3M | — | — | −695.13% |
Outlook Therapeutics quarterly free cash flow
Q3.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2019 | 2019-09-30 | −$5.9M | $3.7M | — | −101.52% |
| Q3 2019 | 2019-06-30 | −$10.5M | −$1.8M | — | −1791.13% |
| Q2 2019 | 2019-03-31 | −$6.3M | $1.4M | — | −984.12% |
| Q1 2019 | 2018-12-31 | −$10.0M | −$271,588 | — | −938.35% |
| Q4 2018 | 2018-09-30 | −$9.7M | −$9.7M | — | −1251.08% |
| Q3 2018 | 2018-06-30 | −$8.7M | −$3.0M | — | −1127.54% |
| Q2 2018 | 2018-03-31 | −$7.7M | −$3.6M | — | −999.38% |
| Q1 2018 | 2017-12-31 | −$9.7M | −$3.8M | — | −1262.64% |
| Q4 2017 | 2017-09-30 | $55,874 | $10.8M | — | +1.93% |
| Q3 2017 | 2017-06-30 | −$5.7M | $10.8M | — | −1883.29% |
| Q2 2017 | 2017-03-31 | −$4.2M | $3.0M | — | −1370.32% |
| Q1 2017 | 2016-12-31 | −$6.0M | $6.4M | — | −1975.99% |
| Q4 2016 | 2016-09-30 | −$10.7M | — | — | −2161.82% |
| Q3 2016 | 2016-06-30 | −$16.5M | −$3.0M | — | −3332.90% |
| Q2 2016 | 2016-03-31 | −$7.1M | — | — | −714.16% |
| Q1 2016 | 2015-12-31 | −$12.4M | — | — | −1244.00% |
| Q3 2015 | 2015-06-30 | −$13.5M | — | — | −1044.51% |
Outlook Therapeutics free cash flow growth trends
Outlook Therapeutics's latest reported quarter, Q4 2019, generated −$5.9M in free cash flow, an increase of $3.7M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Outlook Therapeutics source filings ↗